Stylage XL Bi-Soft Lidocaine is a high-quality injectable filler designed for volumetric correction of facial defects, such as volume loss in the cheeks, chin, or cheekbones. This product is a hyaluronic acid-based filler enhanced with lidocaine to improve comfort during the procedure. It effectively restores facial contours, providing the skin with firmness and a natural volume.
The Stylage XL Bi-Soft filler is manufactured by Revance Therapeutics, a global leader in the development and production of aesthetic products. This product is the result of the latest advancements in dermatology and aesthetic medicine, combining high efficacy with safety.
Composition. Methods of Application.
Composition:
Hyaluronic Acid: The primary active ingredient that effectively restores skin structure, improving hydration and elasticity.
Lidocaine: An anesthetic compound that reduces pain during injection and makes the procedure more comfortable for the patient.
Hyaluronic acid concentration in the product is 24 mg/ml.
Methods of Application: Stylage XL Bi-Soft is used for deep correction of age-related changes and the restoration of facial tissue volume. The main areas of use include:
Correction of volume loss in the cheeks, chin, temples, and cheekbones.
Restoration of facial contours and reduction of skin sagging.
Treatment of medium-depth wrinkles and skin folds.
The product is injected using a fine needle or cannula, minimizing tissue trauma. The procedure is performed by a qualified specialist in a clinical or cosmetic setting. Results are visible immediately after the injections, and the effects last for up to 12-18 months.
Contraindications.
The Stylage XL Bi-Soft Lidocaine filler has several contraindications that should be considered before undergoing injections:
Individual intolerance to any components of the product, especially hyaluronic acid or lidocaine.
Pregnancy and breastfeeding — the use of this product is not recommended during these periods, as there are no sufficient clinical studies available.
Active inflammatory processes or skin infections in the area of injection.
Autoimmune diseases or blood clotting disorders.
Periodic allergic reactions to anesthetic substances.
Pediatric use: Not recommended for children under 18 years old.
For safe application and optimal results, it is recommended to consult with a qualified specialist beforehand, who will assess the skin condition and determine the most suitable treatment plan.
This description is for informational purposes only.
We use cookies to ensure the proper functioning of our website, to personalize advertisements and other materials, to enable social media features, and to analyze network traffic. We also provide information about how you use our site, our social media partners, advertising and analytics.
